Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.23

Margin Of Safety %

15

Put/Call OI Ratio

0.6

EPS Next Q Diff

EPS Last/This Y

2.3

EPS This/Next Y

0.58

Price

81.71

Target Price

95.66

Analyst Recom

1.53

Performance Q

9.72

Relative Volume

0.63

Beta

0.35

Ticker: AZN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-06AZN85.490.600.61141500
2025-10-07AZN85.860.610.17143329
2025-10-08AZN85.380.590.59148856
2025-10-09AZN85.040.600.28150072
2025-10-10AZN85.170.580.25155892
2025-10-13AZN84.50.580.51147952
2025-10-14AZN85.120.590.38149763
2025-10-15AZN84.830.590.32149801
2025-10-16AZN83.840.600.59149881
2025-10-17AZN84.680.600.32150417
2025-10-20AZN83.880.640.27113858
2025-10-21AZN83.20.620.99116650
2025-10-22AZN83.430.630.23119578
2025-10-23AZN83.40.630.17120850
2025-10-24AZN83.290.600.33124944
2025-10-27AZN84.070.590.61122732
2025-10-28AZN82.620.601.62124696
2025-10-29AZN82.240.610.41126246
2025-10-30AZN82.360.600.23128123
2025-10-31AZN82.380.590.44129337
2025-11-03AZN81.720.600.43125358
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-06AZN85.508.87172.64.57
2025-10-07AZN85.868.86899.44.57
2025-10-08AZN85.378.86668.14.57
2025-10-09AZN85.028.86645.04.57
2025-10-10AZN84.508.86567.64.57
2025-10-13AZN84.498.86716.84.57
2025-10-14AZN85.138.86785.04.57
2025-10-15AZN84.838.86825.74.57
2025-10-16AZN83.818.86759.54.57
2025-10-17AZN84.688.86948.34.57
2025-10-20AZN83.878.86731.14.57
2025-10-21AZN83.208.86614.64.57
2025-10-22AZN83.438.86806.04.57
2025-10-23AZN83.398.86759.74.57
2025-10-24AZN83.308.86817.14.57
2025-10-27AZN84.078.86954.04.57
2025-10-28AZN82.618.86685.04.57
2025-10-29AZN82.238.86572.34.57
2025-10-30AZN82.349.16758.14.57
2025-10-31AZN82.409.16642.24.57
2025-11-03AZN81.719.16630.04.57
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-06AZN0.00-3.700.25
2025-10-07AZN0.00-3.700.25
2025-10-08AZN0.00-3.700.25
2025-10-09AZN0.00-3.700.25
2025-10-10AZN0.00-3.700.18
2025-10-13AZN0.00-3.640.18
2025-10-14AZN0.00-3.640.18
2025-10-15AZN0.00-3.640.18
2025-10-16AZN0.00-3.640.18
2025-10-17AZN0.00-3.640.18
2025-10-20AZN0.00-3.600.18
2025-10-21AZN0.00-3.600.18
2025-10-22AZN0.00-3.600.18
2025-10-23AZN0.00-3.600.18
2025-10-24AZN0.00-3.600.18
2025-10-27AZN0.00-3.500.23
2025-10-28AZN0.00-3.500.23
2025-10-29AZN0.00-3.500.23
2025-10-30AZN0.00-3.500.23
2025-10-31AZN0.00-3.500.23
2025-11-03AZN0.00-4.400.23
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.09

Avg. EPS Est. Current Quarter

1.14

Avg. EPS Est. Next Quarter

1.09

Insider Transactions

Institutional Transactions

-4.4

Beta

0.35

Average Sales Estimate Current Quarter

14763

Average Sales Estimate Next Quarter

15364

Fair Value

94.29

Quality Score

92

Growth Score

97

Sentiment Score

84

Actual DrawDown %

6.8

Max Drawdown 5-Year %

-27.9

Target Price

95.66

P/E

30.65

Forward P/E

15.82

PEG

2.54

P/S

4.48

P/B

5.67

P/Free Cash Flow

22.04

EPS

2.67

Average EPS Est. Cur. Y​

4.57

EPS Next Y. (Est.)

5.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.71

Relative Volume

0.63

Return on Equity vs Sector %

-7.2

Return on Equity vs Industry %

-17.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

6630
Astrazeneca PLC
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading